ijms-logo

Journal Browser

Journal Browser

Urinary Titin: A Novel Biomarker for Muscle Atrophy and Catabolic Conditions

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".

Deadline for manuscript submissions: 25 June 2025 | Viewed by 772

Special Issue Editor


E-Mail Website
Guest Editor
Department of Nutrition and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima 770-8503, Japan
Interests: lifestyle diseases; diabetes; obesity; sarcopenia; energy metabolism; nutrition; medaka (oryzias latipes)

Special Issue Information

Dear Colleagues,

Skeletal muscle atrophy is associated with aging, inactivity, poor nutrition, and diseases such as cancer, COPD, and diabetes. Its progression reduces quality of life, impairs daily activities, increases the risk of conditions such as cardiovascular disease, and shortens life expectancy. Identifying a biomarker for the early and accurate assessment of muscle atrophy and functional decline is thus clinically important.

Muscle cells contain contractile myofibrils, with sarcomeres as their basic units. Sarcomeres are composed of contractile proteins (actin and myosin) and the structural protein titin, which connects Z-lines and M-lines. Titin, a large elastic protein (3000–3700 kDa), acts as a molecular spring, resisting passive stretching. During muscle injury or atrophy, titin is degraded by proteolytic enzymes such as calpains and MMPs, releasing fragments into the bloodstream and urine. Serum titin fragments reflect myocardial injury and skeletal muscle atrophy, while elevated urinary titin levels are observed in muscular dystrophy and ICU patients with acute muscle atrophy. Measuring urinary titin is noninvasive, simple, and repeatable.

The purpose of this Special Issue is to examine urinary titin as a biomarker by investigating its relationship with muscle status during muscle atrophy and recovery, as well as by elucidating the molecular mechanisms underlying titin degradation.

Prof. Dr. Hiroshi Sakaue
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • urinary titin
  • skeletal muscle
  • muscle atrophy
  • sarcopenia
  • biomarker
  • catabolism
  • inflammation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

15 pages, 1215 KiB  
Article
Urinary Titin on the First Postoperative Day Predicts Long-Term Skeletal Muscle Loss in Patients with Gastroenterological Cancer
by Momoko Kyomen, Ayako Tatsumi, Rie Tsutsumi, Yuna Izumi-Mishima, Mizusa Hyodo, Eiji Tanaka, Kohta Iguchi, Kojiro Taura, Hiroaki Terajima, Sachiko Honjo, Akihiro Hamasaki, Kazuhiro Nomura and Hiroshi Sakaue
Int. J. Mol. Sci. 2025, 26(5), 2026; https://doi.org/10.3390/ijms26052026 - 26 Feb 2025
Viewed by 525
Abstract
Perioperative malnutrition is common in patients with gastroenterological cancer and contributes to postoperative skeletal muscle atrophy, which adversely affects their prognosis. Early assessment of skeletal muscle atrophy is crucial for improving postoperative outcomes. This study aimed to evaluate the efficacy of urinary titin [...] Read more.
Perioperative malnutrition is common in patients with gastroenterological cancer and contributes to postoperative skeletal muscle atrophy, which adversely affects their prognosis. Early assessment of skeletal muscle atrophy is crucial for improving postoperative outcomes. This study aimed to evaluate the efficacy of urinary titin as a biomarker for skeletal muscle atrophy. A prospective observational study was conducted, and a total of 34 gastroenterological cancer patients were included. Urinary titin levels were measured using ELISA at admission, postoperative days (POD) 1, 7, and 14, and at 6 months after surgery. Surgical procedure, operative time, cancer stage, postoperative complications, hospital stay, and preoperative and postoperative body composition were evaluated, along with nutritional status and grip strength from admission to 6 months after surgery. Changes in urinary titin levels were measured at the same time points as described above. Preoperatively, the mean urinary titin level was 5.03 pmol/mg Cr, slightly higher than in healthy subjects. Urinary titin peaked at 33.71 (24.30–66.58) pmol/mg/dL Cr on POD1 and was associated with serum free branched-chain amino acid concentrations. Urinary titin on POD1 was significantly correlated with a decrease in skeletal muscle mass (rs −0.361, p = 0.036) and body cell mass (rs −0.361, p = 0.038) at 6 months postoperatively. The grip strength at 6 months postoperatively tended to decrease (rs −0.342, p = 0.052). BMI and serum LDH at admission were associated with urinary titin on POD1 but were not correlated with skeletal muscle loss at 6 months, suggesting that urinary titin on POD1 is an independent biomarker of skeletal muscle atrophy. These data indicate that urinary titin on POD1 can predict long-term skeletal muscle atrophy. Full article
Show Figures

Figure 1

Back to TopTop